MOOG Curlin Infusion Administration Set, REF 340-4130, Non-DEHP Tubing with Non-Vented Bag Spike and Vented 0.2 Micron Filter, packaged 20 sets/carton, sterile. Product Usage: Administration set to be used with the Moog Curlin Infusion Pump. The pump can be used for intravenous, intra-arterial, epidural, subcutaneous, or enteral infusions.

Recall Insight

This FDA Devices action (record #Z-2053-2019) was formally reported on July 31, 2019, with the manufacturer initiating the action on February 27, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Zevex Incorporated (dba MOOG Medical Devices Group) is listed as the recalling firm, operating out of Salt Lake City, UT. Federal records indicate 569/20-set caess units are affected.

The documented reason for this recall is: Administration sets leaked at the filter. Distribution data in the federal record shows the product reached: Distribution was made to GA, IL, KS, MA, MI, and OH. There was no foreign/military/government distribution.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 7 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.